RxDoctor Payments Data

Brian Culp, MD

Orthopaedic Surgery · Princeton, NJNPI 1750693909

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $323,295 of the $382,050 with a category attached, or 84.6%. Medacta USA, Inc. accounts for 75.0% of it on its own, with 18 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$382,050in general payments, 2019–2025

Across 359 payments — averaging $1064.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$287K
  • Johnson & Johnson$40K
  • Medical Device Business Services, Inc.$23K
  • Intellijoint Surgical Inc.$22K
  • Smith+Nephew$9K
  • Zimmer Biomet$678
  • plus $2K from 13 others
$7,826in ownership & investment interests, 2019–2025

Across 1 payment — averaging $7826.43 each. An ownership or investment interest held by the physician or an immediate family member.

  • Intellijoint Surgical Inc.$8K

What the payments were for

  • Consulting fees$323,29585%
  • Travel & lodging$45,80712%
  • Food & beverage$12,9483%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$382,050 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$770,303
Medicare patients
1,041
Services billed
18,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib39$2,309
Meloxicam112$312
Methylprednisolone27$187
Amoxicillin68$161
Gabapentin24$126
Clindamycin Hcl16$45

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Princeton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →